Positive PD-L1 Expression Predicts Worse Outcome in Cutaneous Angiosarcoma

PURPOSE: Programmed death-1 (PD-1) or programmed death ligand-1 (PD-L1) targeted therapies have shown promising survival outcomes in several human neoplasms. However, it is unclear whether the expression of PD-L1 can be correlated to any clinical and pathologic variables in patients with cutaneous a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Akira, Kaira, Kyoichi, Okubo, Yuko, Utsumi, Daisuke, Yasuda, Masahito, Asao, Takayuki, Nishiyama, Masahiko, Takahashi, Kenzo, Ishikawa, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2016
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560454/
https://www.ncbi.nlm.nih.gov/pubmed/28831444
http://dx.doi.org/10.1200/JGO.2016.005843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560454/
https://www.ncbi.nlm.nih.gov/pubmed/28831444
http://dx.doi.org/10.1200/JGO.2016.005843

Ejemplares similares